Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common ...

铁代谢障碍及其改善在慢性肾脏病贫血（以下简称“肾性贫血”）发病和治疗中的重要作用早已被临床医生广泛接受和认可，随着铁代谢的生理及分子学机制被进一步阐明，在临床常规的铁代谢指标之外，铁调素的作用也受到更多关注和重视。金秋十月，中华医学会肾脏病学分会2024年学术年会（CCSN ...

Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...

Explore the potential of Celldex's Barzolvolimab in Phase 3 for CSU, with strong efficacy but safety concerns, promising ...

This work is an important contribution to understanding the role of FGF signaling in the induction of primitive-like cells in a 2D system of human gastrulation. The authors provide compelling evidence ...

Guggenheim analyst Yatin Suneja notes that Celldex (CLDX) presented full data from the Phase 2 trial of barzolvolimab in two ...

Celldex Therapeutics (CLDX) is a clinical-stage biotechnology company that focuses on developing targeted therapies for rare ...

A central question in adult stem cell biology is elucidating the signaling pathways regulating their dynamics and function in diverse physiological and age-related contexts. Muscle stem cells in ...

In a report released yesterday, David Lebowitz from Citi maintained a Buy rating on Celldex (CLDX – Research Report), with a price target ...